Professional Documents
Culture Documents
Reference Intervals and Its Significance in Clinicallaboratory
Reference Intervals and Its Significance in Clinicallaboratory
Reference Intervals and Its Significance in Clinicallaboratory
CLINICAL CHEMISTRY
BY
MLS. JOHN FAVOUR MANA
(INTERN)
SUPERVISED BY:
MLS ABDULAZEEZ ANIBASA
11TH OCTOBER, 2023
1
OUTLINE
• TERMINOLOGIES
• INTRODUCTION
• HISTROCIAL BACKGROUD
• TYPES/ FEATURES REFERENCES INTERVALS
• PROCESS/ METHOD FOR VERIFYING REFERENCES INTERVALS
• DATA ANALYSIS FOR TRANSFERENCE
• FACTORS AFFECTING REFERENCES INTERVALS
• SIGNIFICANCE OF REFERENCE INTERVALS IN CLINICAL
CHEMISTRY
• CONCLUSION
• RECOMMENDATION
• TAKE HOME MESSAGE
• REFERENCES
2
LIST OF ABBREVIATION
• CLSI: Clinical and Laboratory Standards Institute
• IFCC: International Federation of Clinical Chemistry
• ISO: International Organization for Standardization
• NCCLS: National Committee for Clinical Laboratoryoratory
Standards
• QMS: Quality Management System
3
TERMINOLOGIES 1/2
• REFERENCE INDIVIDUAL is an individual selected for comparison
using defined criteria.
• REFERENCE POPULATION consists of all possible reference
individuals.
• REFERENCE SAMPLE GROUP is an adequate number of reference
individuals taken to represent the reference population.
• REFERENCE VALUE is the value (test result) obtained by observation or
measurement of a particular quantity on an individual belonging to a
reference sample group. (Higgins, 2009)
4
TERMINOLOGIES 2/2
(Horowitz, 2008)
7
INTRODUCTION 2/4
8
INTRODUCTION 3/4
(Horowitz, 2008)
9
INTRODUCTION 4/4
10
HISTORICAL BACKGROUND 1/2
All reference intervals should have a lower and upper limit, values above
upper or below lower limit may be abnormal.
X Y
LOWER UPPER
LIMITS LIMITS
NORMAL
VALUES
(NCCLS, 2000)
16
ESTABLISHING A REFERENCE INTERVAL
(NCCLS, 1999)
17
LIMITATIONS OF ESTABLISHING REFERENCE
INTERVALS
(NCCLS, 1999)
19
PROCESS FOR VERIFYING A REFERENCE
INTERVAL 1/3
• Define the analyte (measured) for which the reference interval is
being verified.
• Define the method used, and analytical specificity.
• Define important pre-analytical considerations together with any
actions in response to the interference.
20
PROCESS FOR VERIFYING A REFERENCE
INTERVAL 2/3
• Define the principle behind the reference interval (i.e. central 95%
etc.)
• Describe the data source(s), including: number of subjects, nature of
subjects.
• Define considerations of partitioning based on age, sex etc. depending
on the analyte of interest.
21
PROCESS FOR VERIFYING A REFERENCE
INTERVAL 3/3
• Define the number of significant figures, i.e. the degree of
rounding (3-4 decimal places).
• Define the clinical relevance of the reference limits.
• Consider the use of common reference intervals (i.e. without
reference to age, sex, etc. as seen in plasma Glucose levels).
• Quality control.
22
STATISTICAL METHODS FOR REFERENCE
INTERVAL
• Non-Gaussian distribution
• Percentile method
• Gaussian curve
• Normal distribution
• Log-normal distribution
• Logarithmized sample values
• Bimodal distribution
(Jones and Barker., 2008)
23
NON-GAUSSIAN DISTRIBUTION 1/3
• Non-Gaussian refers to data or distributions that do not follow a
Gaussian distribution (i.e. normal distribution).
• For data that is non-Gaussian (e.g. skewed or curved), the data can be
mathematically transformed, e.g. to logarithms. If it yields a Gaussian
distribution, the geometric mean ± 2 SD can be used for reference
interval determination.
(Walton, 2012)
24
NON-GAUSSIAN DISTRIBUTION 2/3
(Walton, 2012)
25
NON-GAUSSIAN DISTRIBUTION 3/3
28
BIMODAL DISTRIBUTION 2/2
29
DATA ANALYSIS TO VERIFY TRANSFERENCE
The CLSC allows less vigorous studies to verify a reference interval with
as few as 20 subject specimen.
The manufacturer’s reported 95% reference limits may be considered
valid if no more than 10% of the test subjects fall outside the original
reported limits. If more than 10% of the values fall outside of the
proposed interval, an additional 20 or more specimens should be
analyzed.
(CLSI, 2008)
30
DATA ANALYSIS TO VERIFY TRANSFERENCE
Most patient data are not normally distributed because, these data may be
skewed or exhibit multiple centiles (Bimodal, trimodal etc.). Therefore,
the analysis of patient data require “non-parametric” approach, and this is
encountered in Reference Interval Studies.
When possible, clinical Laboratory rely on manufacturers to determine
reference intervals. This avoids the expensive and lengthy process of
establishing a reference range interval on a minimum of 120 healthy
people. (CLSI, 2008)
31
DATA ANALYSIS TO VERIFY TRANSFERENCE
32
DATA ANALYSIS TO VERIFY TRANSFERENCE
33
FACTORS AFFECTING REFERENCES VALUES
• Age • Exercise
• Gender • Time of sampling
• Diet • Type of specimen
• Ethnicity • Geographic locations
• Physical size • Analytical methods
• Pregnancy
34
SIGNIFICANCE OF REFERENCE INTERVALS IN
CLINICAL CHEMISTRY 1/3
• Diagnostic Tool: Reference intervals provide a basis for determining
whether a patient's test results are within a normal, healthy range or
indicate a potential medical issue.
• Treatment Monitoring: Doctors use reference intervals to monitor
patients' progress during treatment.
• Research and Clinical Trials: Reference intervals serve as a standard in
clinical research and drug trials, helping researchers assess the impact of
new treatments on patients' health. (Koerbin et al., 2016)
35
SIGNIFICANCE OF REFERENCE INTERVALS IN
CLINICAL CHEMISTRY 2/3
• Quality Control: Laboratories use reference intervals to validate the
accuracy and precision of their testing methods. Consistently producing
results within established reference intervals is a sign of quality in
Laboratory testing.
• Population Health: Reference intervals are useful for studying population
health trends and variations. They can help identify regional or
demographic differences in health.
(Koerbin et al., 2016)
36
SIGNIFICANCE OF REFERENCE INTERVALS IN
CLINICAL CHEMISTRY 3/3
• Risk Assessment: Reference intervals help assess an individual's risk for
certain diseases. For example, cholesterol levels outside the reference
interval may indicate a higher risk of heart disease.
• Patient Education: Doctors can use reference intervals to educate patients
about their health and the significance of their test results.
37
CONCLUSION
Reference intervals are essential tools in clinical Laboratory that aid in
accurate diagnosing, proper treatment and patients monitoring. They provide
valuable context for interpreting individual test results.
38
RECOMMENDATION
• Chemical Pathology department in FMC Bida should verify the
Reference Interval for all test analytes.
• Therefore, Medical Laboratory scientist should continue to participate
in quality improvement activities that deal with relevant areas and
outcomes of patients care.
• Because, according to ISO 1518 (4.12.4), Medical Laboratory Shall
implement quality indicator (quality control) to systematically monitor
and evaluate Laboratory’s contribution to patient care.
39
TAKE HOME MESSAGE
40
REFERENCE
Bangert, S., Marshall, W. J., & Leonard, W. (2008). Clinical
biochemistry: metabolic and clinical aspects. Elsevier. 4(3): 10-11.
Ceriotti, F., Hinzmann, R., & Panteghini, M. (2009). Reference
intervals: the way forward. Sage Journal. 1(46):1.
Clinical and Laboratory Standard Institute (CLSI). (2008) Defining,
establishing, and verifying reference intervals in the clinical
Laboratoryoratory; approved guideline, 3rd ed. CLSI document. C28-
P3.
Fiseha, T., Alemayehu, E., Adem, O. M., Eshetu, B., & Gebreweld, A.
(2022). Reference intervals for common clinical chemistry
parameters in healthy adults of Northest Ethiopia. Plos ONE.
17(11):10-13.
41
REFERENCE
Hessing, T. (2022). Bimodal distribution. Six sigma. 1-3.
Higgins, C. (2009). An introduction to reference intervals (1) – some
theoretical considerations. Acutecaretesting.org.
Horowitz, G. (2008). Reference intervals: practical Aspects. The
electronic Journal of the International Federation of Clinical C
hemistry. 19(2):95-105.
Jones, G., & Barker, A. (2008). Reference intervals. Clinical
Biochemistry Review. 1(29):93-97.
Koerbin, G., Cavanaugh, J., Potter, J. M., Abhayaratna, W. P., &
West, N. P. (2016). Estimation of reference intervals for aminotransferases
and derivation of de-identified reference intervals for gamma glutamyl
transferase in a healthy Australian population. Clinical Biochemistry.
49(13-14):1037-1040.
42
REFERENCE
Martins, J. W. (2017). Sampling Distribution, confidence interval,
percentile. Oneclass.com. 2
National Committee for Clinical Laboratoryoratory Standards (NCCLS).
(2000). How to define and determine reference intervals in the clinical
Laboratoryoratory; approved guideline. Wanye publishing. C28-A2.
Özarda, Y. (2016). Reference intervals: current status, recent developments
and future considerations. Biochemical Medicine. 1(26):5–16.
Reed, A., Henry, R., Mason, W. (1971) Influence of Statistical Method
Used on Resulting Estimate of Normal Range. Clinical
Chemistry. 17:275-276.
Walton, R. M. (2012). Subject-based reference values: biological variation,
individuality, and reference change values. Veterinary Clinical
pathology. 2(41):175-181.
43